PMID- 28982738 OWN - NLM STAT- MEDLINE DCOM- 20190110 LR - 20201209 IS - 1522-1504 (Electronic) IS - 1040-0605 (Linking) VI - 314 IP - 1 DP - 2018 Jan 1 TI - Intranasal administration of recombinant progranulin inhibits bronchial smooth muscle hyperresponsiveness in mouse allergic asthma. PG - L215-L223 LID - 10.1152/ajplung.00575.2016 [doi] AB - Progranulin (PGRN) is a growth factor with multiple biological functions and has been suggested as an endogenous inhibitor of Tumor necrosis factor-alpha (TNF-alpha)-mediated signaling. TNF-alpha is believed to be one of the important mediators of the pathogenesis of asthma, including airway hyperresponsiveness (AHR). In the present study, effects of recombinant PGRN on TNF-alpha-mediated signaling and antigen-induced hypercontractility were examined in bronchial smooth muscles (BSMs) both in vitro and in vivo. Cultured human BSM cells (hBSMCs) and male BALB/c mice were used. The mice were sensitized and repeatedly challenged with ovalbumin antigen. Animals also received intranasal administrations of recombinant PGRN into the airways 1 h before each antigen inhalation. In hBSMCs, PGRN inhibited both the degradation of IkappaB-alpha (an index of NF-kappaB activation) and the upregulation of RhoA (a contractile machinery-associated protein that contributes to the BSM hyperresponsiveness) induced by TNF-alpha, indicating that PGRN has an ability to inhibit TNF-alpha-mediated signaling also in the BSM cells. In BSMs of the repeatedly antigen-challenged mice, an augmented contractile responsiveness to acetylcholine with an upregulation of RhoA was observed: both the events were ameliorated by pretreatments with PGRN intranasally. Interestingly, a significant decrease in PGRN expression was found in the airways of the repeatedly antigen-challenged mice rather than those of control animals. In conclusion, exogenously applied PGRN into the airways ameliorated the antigen-induced BSM hyperresponsiveness, probably by blocking TNF-alpha-mediated response. Increasing PGRN levels might be a promising therapeutic for AHR in allergic asthma. FAU - Chiba, Yoshihiko AU - Chiba Y AD - Department of Physiology and Molecular Sciences, Hoshi University , Tokyo , Japan. AD - Department of Biology, Hoshi University , Tokyo , Japan. FAU - Danno, Shunta AU - Danno S AD - Department of Biology, Hoshi University , Tokyo , Japan. FAU - Suto, Rena AU - Suto R AD - Department of Biology, Hoshi University , Tokyo , Japan. FAU - Suto, Wataru AU - Suto W AD - Department of Physiology and Molecular Sciences, Hoshi University , Tokyo , Japan. FAU - Yamane, Yamato AU - Yamane Y AD - Department of Physiology and Molecular Sciences, Hoshi University , Tokyo , Japan. FAU - Hanazaki, Motohiko AU - Hanazaki M AD - Department of Anesthesiology and Intensive Care Medicine, Kawasaki Medical School , Kurashiki , Japan. FAU - Katayama, Hiroshi AU - Katayama H AD - Department of Anesthesiology and Intensive Care Medicine, Kawasaki Medical School , Kurashiki , Japan. FAU - Sakai, Hiroyasu AU - Sakai H AD - Department of Analytical Pathophysiology, School of Pharmacy, Hoshi University , Tokyo , Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20171005 PL - United States TA - Am J Physiol Lung Cell Mol Physiol JT - American journal of physiology. Lung cellular and molecular physiology JID - 100901229 RN - 0 (Granulins) RN - 0 (Grn protein, mouse) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Progranulins) RN - 0 (Recombinant Proteins) SB - IM MH - Administration, Intranasal MH - Animals MH - Asthma/*physiopathology MH - Bronchi/*physiopathology MH - Bronchial Hyperreactivity/etiology/metabolism/*prevention & control MH - Cells, Cultured MH - Granulins MH - Humans MH - Intercellular Signaling Peptides and Proteins/*administration & dosage MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Muscle, Smooth/metabolism/*pathology MH - Progranulins MH - Recombinant Proteins/*administration & dosage MH - Respiratory Hypersensitivity/etiology/metabolism/*prevention & control MH - Signal Transduction OTO - NOTNLM OT - airway hyperresponsiveness OT - asthma OT - bronchial smooth muscle OT - progranulin (PGRN) OT - tumor necrosis factor-alpha (TNF-alpha) EDAT- 2017/10/07 06:00 MHDA- 2019/01/11 06:00 CRDT- 2017/10/07 06:00 PHST- 2017/10/07 06:00 [pubmed] PHST- 2019/01/11 06:00 [medline] PHST- 2017/10/07 06:00 [entrez] AID - ajplung.00575.2016 [pii] AID - 10.1152/ajplung.00575.2016 [doi] PST - ppublish SO - Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L215-L223. doi: 10.1152/ajplung.00575.2016. Epub 2017 Oct 5.